23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

An Experienced Biopharma Leadership Team 100+ years of experience: Genentech, Amgen, Gilead, GSK Loxo, Achaogen, ProNeurotech, National Cancer Institute, Albert Einstein College of Medicine From Left to Right: Adam Auton Monica Viziano Jennifer Low Bill Richards Kenneth Hillan Joe Arron Vice President, Human Genetics Vice President, Portfolio Strategy and AM Head of Therapeutics Development Vice President, Target and Drug Discovery Chief Therapeutics Officer Chief Scientific Officer, Therapeutics https://www.23andme.com/therapeutics/ 6 2aanthe
View entire presentation